Cargando…

EUS-guided thrombin injection for management of gastric fundal varices

BACKGROUND AND STUDY AIMS : Cyanoacrylate glue is recommended first-line endoscopic therapy for gastric fundal varices but it is difficult to use and carries a risk of embolization. Thrombin is preferred by many in the UK, but its effectiveness can be difficult to establish at endoscopy and the rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Frost, John W., Hebbar, Srisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979194/
https://www.ncbi.nlm.nih.gov/pubmed/29868631
http://dx.doi.org/10.1055/a-0599-0440
_version_ 1783327642055868416
author Frost, John W.
Hebbar, Srisha
author_facet Frost, John W.
Hebbar, Srisha
author_sort Frost, John W.
collection PubMed
description BACKGROUND AND STUDY AIMS : Cyanoacrylate glue is recommended first-line endoscopic therapy for gastric fundal varices but it is difficult to use and carries a risk of embolization. Thrombin is preferred by many in the UK, but its effectiveness can be difficult to establish at endoscopy and the rate of re-bleeding is higher. Endoscopic ultrasound (EUS) can help assess variceal blood flow and has the potential to improve both targeting and effectiveness of injection therapy. Whereas there is already some data for its use with glue, little data currently exist in relation to its use with thrombin. PATIENTS AND METHODS : We present a series of patients treated with EUS-guided thrombin injection over the last 4 years. Thrombin was injected under EUS guidance with the intention of obliterating flow within the fundal varices. Outcomes reviewed included whether haemostasis was achieved, the dose of thrombin required for endosonographic variceal obliteration, the incidence of re-bleeding, and procedural related adverse events. RESULTS : Eight patients received EUS-guided thrombin: 3 with active bleeding and 5 as elective prevention. In 2/3 (66 %) patients with active bleeding haemostasis was achieved after a single dose with complete variceal obliteration. 1/3 (33 %) had no alteration in blood flow despite 10 000 IU. None of the elective prevention group had further bleeding and obliteration was observed in 4/5 (80 %). A range of 600 to 10 000 IU of thrombin was used and there were no adverse procedure-related outcomes. CONCLUSIONS : Our results are promising and suggest that EUS-guided thrombin injection may have a role in managing bleeding from gastric fundal varices.
format Online
Article
Text
id pubmed-5979194
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-59791942018-06-04 EUS-guided thrombin injection for management of gastric fundal varices Frost, John W. Hebbar, Srisha Endosc Int Open BACKGROUND AND STUDY AIMS : Cyanoacrylate glue is recommended first-line endoscopic therapy for gastric fundal varices but it is difficult to use and carries a risk of embolization. Thrombin is preferred by many in the UK, but its effectiveness can be difficult to establish at endoscopy and the rate of re-bleeding is higher. Endoscopic ultrasound (EUS) can help assess variceal blood flow and has the potential to improve both targeting and effectiveness of injection therapy. Whereas there is already some data for its use with glue, little data currently exist in relation to its use with thrombin. PATIENTS AND METHODS : We present a series of patients treated with EUS-guided thrombin injection over the last 4 years. Thrombin was injected under EUS guidance with the intention of obliterating flow within the fundal varices. Outcomes reviewed included whether haemostasis was achieved, the dose of thrombin required for endosonographic variceal obliteration, the incidence of re-bleeding, and procedural related adverse events. RESULTS : Eight patients received EUS-guided thrombin: 3 with active bleeding and 5 as elective prevention. In 2/3 (66 %) patients with active bleeding haemostasis was achieved after a single dose with complete variceal obliteration. 1/3 (33 %) had no alteration in blood flow despite 10 000 IU. None of the elective prevention group had further bleeding and obliteration was observed in 4/5 (80 %). A range of 600 to 10 000 IU of thrombin was used and there were no adverse procedure-related outcomes. CONCLUSIONS : Our results are promising and suggest that EUS-guided thrombin injection may have a role in managing bleeding from gastric fundal varices. © Georg Thieme Verlag KG 2018-06 2018-05-25 /pmc/articles/PMC5979194/ /pubmed/29868631 http://dx.doi.org/10.1055/a-0599-0440 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Frost, John W.
Hebbar, Srisha
EUS-guided thrombin injection for management of gastric fundal varices
title EUS-guided thrombin injection for management of gastric fundal varices
title_full EUS-guided thrombin injection for management of gastric fundal varices
title_fullStr EUS-guided thrombin injection for management of gastric fundal varices
title_full_unstemmed EUS-guided thrombin injection for management of gastric fundal varices
title_short EUS-guided thrombin injection for management of gastric fundal varices
title_sort eus-guided thrombin injection for management of gastric fundal varices
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979194/
https://www.ncbi.nlm.nih.gov/pubmed/29868631
http://dx.doi.org/10.1055/a-0599-0440
work_keys_str_mv AT frostjohnw eusguidedthrombininjectionformanagementofgastricfundalvarices
AT hebbarsrisha eusguidedthrombininjectionformanagementofgastricfundalvarices